<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02051907</url>
  </required_header>
  <id_info>
    <org_study_id>KAM-RAD-01</org_study_id>
    <nct_id>NCT02051907</nct_id>
  </id_info>
  <brief_title>Clinical Study to Evaluate Safety and Efficacy of KAM1403 Gel to Treat Radiation Dermatitis</brief_title>
  <acronym>kam1403</acronym>
  <official_title>A BLIND, CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF KAM1403 GEL TREATMENT IN PATIENTS WITH RADIATION DERMATITIS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kamedis Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kamedis Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main purpose of this study is to demonstrate the safety and efficacy of KAM1403 GEL in
      reducing the symptoms of mild to moderate Radiation Dermatitis. Efficacy will be evaluated by
      comparing symptoms assessment during and post radiotherapy: erythema, desquamation, edema,
      moist desquamation and ulceration in the KAM1403 Gel treated group versus a group of subjects
      treated with the Aloe vera Gel (the control group). In addition, a comparison will be made
      between subjects' self evaluation in the treatment group versus the control group. Safety
      will be determined by the number and severity of Adverse Events Device-Related.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">April 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in Radiation dermatitis symptoms</measure>
    <time_frame>Day 0, weeks 2, 4, 6.5, 8.5</time_frame>
    <description>Changes in Radiation dermatitis symptoms assessment during and post radiotherapy (erythema, desquamation, edema, moist desquamation and ulceration) using the Radiation Therapy Oncology Group toxicity scoring system in the treatment group versus the control group</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subjects' self evaluation</measure>
    <time_frame>Day 0, weeks 2, 4, 6.5, 8.5</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Adverse Events</measure>
    <time_frame>Day 0, weeks 2, 4, 6.5, 8.5</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Radiation Dermatitis</condition>
  <arm_group>
    <arm_group_label>KAM1403 Gel</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A group treated with KAM1403 for the study period.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Aloevera Gel</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>A group treated with Aloevera Gel for the study period</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>KAM1403 Gel</intervention_name>
    <arm_group_label>KAM1403 Gel</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>aloevera gel</intervention_name>
    <arm_group_label>Aloevera Gel</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female above 18 years of age

          -  Diagnosed with breast cancer and scheduled to receive postoperative radiotherapy

          -  Treatment of regional lymph nodes (i.e. axillary, supraclavicular, or internal
             mammary) is allowed.

          -  Schedule for breast radiotherapy (RT) to a dose of 50 Gy in 2 Gy/fx, for 5 weeks and
             then a boost to the lumpectomy cavity.

          -  Minimum of 3 weeks from chemotherapy to start of radiation therapy.

          -  Patient agrees to use only the test products during the study period

        Exclusion Criteria:

          -  Tumor involvement of the skin

          -  Patient has another dermatological disease/condition that could interfere with
             clinical evaluation including infected atopic dermatitis lesions

          -  Patient has a previous history of allergy to the ingredients of the tested
             formulations

          -  Paget's disease of the nipple.

          -  Pregnant or lactating females
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Diana Matchiavsky, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sourasky Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Helena Gryner, M.Sc.</last_name>
    <phone>+972 73 7969040</phone>
    <email>Helena@Kamedis.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sourasky Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Diana Matchiavsky, MD</last_name>
      <phone>972 3 697 4815</phone>
      <email>dianam@tlvmc.gov.il</email>
    </contact>
    <investigator>
      <last_name>Diana Matchiavsky, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <link>
    <url>http://www.kamedis.com</url>
    <description>Sponsor's site</description>
  </link>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 30, 2014</study_first_submitted>
  <study_first_submitted_qc>January 30, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 31, 2014</study_first_posted>
  <last_update_submitted>January 30, 2014</last_update_submitted>
  <last_update_submitted_qc>January 30, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 31, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dermatitis</mesh_term>
    <mesh_term>Radiodermatitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

